Hypoxia in prostate cancer: a powerful shield against tumour destruction?
about
Nuclear expression of dynamin-related protein 1 in lung adenocarcinomas.Angiogenesis inhibitors in the treatment of prostate cancer.Poly (ADP-ribose) polymerase inhibitor: an evolving paradigm in the treatment of prostate cancer.Fisetin induces autophagic cell death through suppression of mTOR signaling pathway in prostate cancer cells.Prostate cancer cell lines under hypoxia exhibit greater stem-like properties.Longitudinal magnetic resonance imaging-based assessment of vascular changes and radiation response in androgen-sensitive prostate carcinoma xenografts under androgen-exposed and androgen-deprived conditionsVascular responses to radiotherapy and androgen-deprivation therapy in experimental prostate cancer.Hypoxic tumor kinase signaling mediated by STAT5A in development of castration-resistant prostate cancer.The role of hypoxia-inducible factor 1α in determining the properties of castrate-resistant prostate cancers.The complexities of obesity and diabetes with the development and progression of pancreatic cancer.Adaptive therapy.Distinct phenotypes of human prostate cancer cells associate with different adaptation to hypoxia and pro-inflammatory gene expression.Impact of hypoxia on the metastatic potential of human prostate cancer cells.Liposomal doxorubicin improves radiotherapy response in hypoxic prostate cancer xenograftsHypoxia-inducible miR-182 enhances HIF1α signaling via targeting PHD2 and FIH1 in prostate cancer.Hypoxia regulates Notch-3 mRNA and receptor activation in prostate cancer cells.Clinical Response of Metastatic Breast Cancer to Multi-targeted Therapeutic Approach: A Single Case Report.Fractionated radiation exposure amplifies the radioresistant nature of prostate cancer cells.Taking advantage of tumor cell adaptations to hypoxia for developing new tumor markers and treatment strategies.K63-polyubiquitinated HAUSP deubiquitinates HIF-1α and dictates H3K56 acetylation promoting hypoxia-induced tumour progressionHypoxia, notch signalling, and prostate cancer.The effects of nonspecific HIF1α inhibitors on development of castrate resistance and metastases in prostate cancer.Methylseleninic acid elevates REDD1 and inhibits prostate cancer cell growth despite AKT activation and mTOR dysregulation in hypoxia.MicroRNAs as putative mediators of treatment response in prostate cancer.Old but new methods in radiation oncology: hyperbaric oxygen therapy.To die or to survive, a fatal question for the destiny of prostate cancer cells after androgen deprivation therapy.The nrf1 and nrf2 balance in oxidative stress regulation and androgen signaling in prostate cancer cells.Oxygen supply maps for hypoxic microenvironment visualization in prostate cancer.Downregulation of key regulatory proteins in androgen dependent prostate tumor cells by oncolytic reovirus.ERRα augments HIF-1 signalling by directly interacting with HIF-1α in normoxic and hypoxic prostate cancer cells.Beyond the limits of oxygen: effects of hypoxia in a hormone-independent prostate cancer cell line.Exposure of Prostate to Lipopolysaccharide and Hypoxia Potentiates Neoplastic Behavior and Risk for Prostate Carcinogenesis In Vivo.Methylseleninic acid downregulates hypoxia-inducible factor-1α in invasive prostate cancer.Nuclear co-localization and functional interaction of COX-2 and HIF-1α characterize bone metastasis of human breast carcinoma.Noninvasive multiparametric imaging of metastasis-permissive microenvironments in a human prostate cancer xenograftTargeting MicroRNAs in Prostate Cancer Radiotherapy.Inhibition of Hypoxia Inducible Factor Alpha and Astrocyte-Elevated Gene-1 Mediates Cryptotanshinone Exerted Antitumor Activity in Hypoxic PC-3 Cells.Gene expression analysis in prostate cancer: the importance of the endogenous control.Histone demethylase PHF8 regulates hypoxia signaling through HIF1α and H3K4me3.Profiling of a panel of radioresistant prostate cancer cells identifies deregulation of key miRNAs.
P2860
Q33467361-73FA6E9D-D626-4E46-B30D-DB4D1B0183F9Q33611121-5CC54622-BE61-4903-AD02-AD18B0DD5E8BQ33621410-138E205A-4E8A-4E48-B475-13DA1211F1CEQ34042356-5F78A928-3B6B-470B-AB84-523C2EAD0CA9Q34117287-09865A51-573E-4C84-A63A-FFF475B504F6Q34177229-94F6507D-7E15-468E-92FA-A537A000E35EQ34279214-AE2AA5F9-4DEB-44B3-BDB1-8318FE878D43Q34344798-EB3B2D0E-ED84-4B53-8698-59F611457ED9Q34559250-043DE6AC-37F9-4D42-BBFA-5886E4D1F059Q34669361-88CBAC28-9C6A-409C-9253-D919D2AAAA37Q34984307-465C2A17-1A94-4717-A9C5-95BD847CF1D2Q35163931-1D710C32-C1B3-4928-9FC1-1F956DB85917Q35186588-EC19FFF7-E6D3-4388-A424-2B0A539BB712Q35352837-5518ED1D-83A2-4A31-B815-61C4C9A2F508Q35884549-BBF4A1D2-393B-4952-9CBA-EB7C70AD6F2FQ37097040-FE25AE2C-D400-486F-BD7C-571C85105F76Q37129903-A9C44A37-3F68-428B-8DAD-498CC6F24F78Q37310865-012F0198-609A-4455-8559-FFE64550F19FQ37426436-FA500B7C-818B-45ED-AD47-FC4432FF773EQ37500984-D854A7F8-536D-44FF-AC3A-2D7F22032085Q37589392-594E2BE9-E2BD-4720-83BA-D991042484DFQ37703367-F9434360-A942-44FF-A249-B3D07ADB8B1BQ37703369-CFA69C00-F423-40D0-B33C-600DA2F60D24Q38011943-CD39FCE5-3429-4A3D-A4D5-8F0E21BB847FQ38086801-D45F88F6-0D4C-4883-90D5-359436C5741AQ38161350-59853C91-10BD-43BF-AA1F-44E9C538E399Q38166575-FDBD009E-69E5-4C6D-A9F2-E8E28DA0C27AQ38595654-89AFD5BF-B21E-4E03-9A4A-60884999A576Q38844346-ADEAE285-2797-4583-93E3-6A4177C6F0DCQ39034345-9390A796-8749-409D-8E8C-F7F2A25E4FE5Q39069174-4C292F09-3A4F-4A6E-A616-A13587E21E40Q39323810-EFF7663A-8C1F-4CC6-A177-950B812E1A78Q39557196-5B5DCE25-C526-4555-895C-A4753FFE7ED1Q39633239-75A11F58-0A29-42A8-B945-414F9103AD84Q39782755-0FF93D5C-9DD2-4202-9585-725498A52B4EQ41239908-FDF4B6B1-B4FE-41CA-96F7-143CB866AAAEQ42406107-C297201C-1277-446E-81B1-198F572834B9Q47215788-BCE011C3-402A-4640-8F45-B17879F98799Q48714639-2A2000FC-E4A1-4CD2-8371-02B703EDD2FBQ52721513-ACBB7730-0B0F-463C-897B-9FFDF86CFD50
P2860
Hypoxia in prostate cancer: a powerful shield against tumour destruction?
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 10 March 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Hypoxia in prostate cancer: a powerful shield against tumour destruction?
@en
Hypoxia in prostate cancer: a powerful shield against tumour destruction?
@nl
type
label
Hypoxia in prostate cancer: a powerful shield against tumour destruction?
@en
Hypoxia in prostate cancer: a powerful shield against tumour destruction?
@nl
prefLabel
Hypoxia in prostate cancer: a powerful shield against tumour destruction?
@en
Hypoxia in prostate cancer: a powerful shield against tumour destruction?
@nl
P2093
P1476
Hypoxia in prostate cancer: a powerful shield against tumour destruction?
@en
P2093
P304
P356
10.1016/J.CTRV.2008.01.006
P50
P577
2008-03-10T00:00:00Z